Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Motor Activity × peficitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 1 Lymphoma, Follicular 1 Colitis, Ulcerative 1

Interventions

Exercise 9 Methods 2 Behavior Therapy 2 secukinumab 1 peficitinib 1 lime 1 Waiting Lists 1 Telemedicine 1 Nutrition Assessment 1 Memantine 1 High-Intensity Interval Training 1 Health 1 Exergaming 1 Diet 1 Counseling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01959282 2019-01-04

A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Janssen Research & Development, LLC

Phase 2 Completed

Colitis, Ulcerative, Lymphoma, Follicular, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡